Cita APA (7a ed.)
Elkilany, A., Geisel, D., Müller, T., Fischer, A., & Denecke, T. (2021). Gadoxetic acid-enhanced MRI in primary sclerosing cholangitis: Added value in assessing liver function and monitoring disease progression. Abdominal Radiology, 46(3), 979-992.
Cita Chicago Style (17a ed.)
Elkilany, Aboelyazid, Dominik Geisel, Tobias Müller, Andreas Fischer, y Timm Denecke. "Gadoxetic Acid-enhanced MRI in Primary Sclerosing Cholangitis: Added Value in Assessing Liver Function and Monitoring Disease Progression." Abdominal Radiology 46, no. 3 (2021): 979-992.
Cita MLA (9a ed.)
Elkilany, Aboelyazid, et al. "Gadoxetic Acid-enhanced MRI in Primary Sclerosing Cholangitis: Added Value in Assessing Liver Function and Monitoring Disease Progression." Abdominal Radiology, vol. 46, no. 3, 2021, pp. 979-992.
Precaución: Estas citas no son 100% exactas.